11月27日，中南大学湘雅二医院血液内科彭宏凌教授团队在国际权威期刊Journal of Clinical Investigation（IF=19.4）发表了题为《IL-2-inducible T cell kinase deficiency sustains chimeric antigen receptor T cell therapy against tumor cells》的原创性研究论文 ...

T therapy targeting p95HER2 shows complete and durable tumor responses in HER2+ breast cancer preclinical models. Combining ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells are too varied ...

Invented at UCSF, this smarter gene therapy is revolutionizing the field of precision cancer care and may, one day, cure the ...

CART-007, an anti-CD7 CAR T-cell therapy for relapsed/refractory T-cell acute lymphoblastic leukemia or T-cell lymphoblastic ...